Evidence is challenging panacea narratives around GLP-1 drugs while underscoring the need for clinical endpoints before expanding indications. Climate risk is visibly moving asset prices and exposing food-quality trade-offs, pushing investors and policymakers toward pragmatic, deployable solutions. Reinterpretations in astronomy, paleontology, and negotiation research show how updated data can reset assumptions without headline-grabbing moonshots.
Reddit
#climate change
#financial markets
#biomedical research
#agriculture
#astronomy
